To investigate the action of METTL3 on the drug resistance of BC cells, METTL3 was silenced in MCF-7/ADR cells, followed by evaluation of cell viability and apoptosis results using an MTT assay (Supplementary Fig. 1a) and flow cytometric analysis (Supplementary Fig. 1b), respectively. Here, METTL3 is linked to breast cancer.